Hepatocarcinogenic activities of hydroxymethyl derivatives of 4-(N,N-dimethylamino)azobenzene in ACI/N rats. 1987

H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
Department of Pathology, Gifu University School of Medicine, Japan.

The hepatocarcinogenic potencies of three newly identified hydroxymethyl derivatives of 4-(N,N-dimethylamino)azobenzene [(DAB) CAS: 60-11-7], i.e., 2'-CH2OH-DAB, 3'-CH2OH-DAB, and 4'-CH2OH-DAB, were strictly evaluated in a long-term test (400 days) and compared to the potency of 3'-CH3-DAB. ACI/N rats, known to be less sensitive to azo dye carcinogenesis, were given one of these compounds in their diets for 120 days. The incidence of hepatocellular carcinoma in group 2 (20/20), which was given 3'-CH2OH-DAB, was much higher than that in any of the other groups: group 1 (2'-CH2OH-DAB; 4/19), group 3 (4'-CH2OH-DAB; 1/25), or group 4 (3'-CH3-DAB; 3/24). These data suggest that 3'-CH2OH-DAB is the most potent hepatocarcinogen in the series of azo dyes. Possible reasons for the potency of the chemical are discussed.

UI MeSH Term Description Entries
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008749 Methyldimethylaminoazobenzene A very potent liver carcinogen. MeDAB,3'-Methyl-4-dimethylaminoazobenzene,Dimethyl-p-(m-tolylazo)aniline,3' Methyl 4 dimethylaminoazobenzene
D011912 Rats, Inbred ACI An inbred strain of rat that is widely used in BIOMEDICAL RESEARCH. Applications include the study of spontaneous NEOPLASMS; CHRONIC KIDNEY DISEASES, and CONGENITAL ABNORMALITIES. Rats, Inbred A x C 9935 Irish,Rats, ACI,ACI Rat,ACI Rat, Inbred,ACI Rats,ACI Rats, Inbred,Inbred ACI Rat,Inbred ACI Rats,Rat, ACI,Rat, Inbred ACI
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004124 p-Dimethylaminoazobenzene A reagent used mainly to induce experimental liver cancer. According to the Fourth Annual Report on Carcinogens (NTP 85-002, p. 89) published in 1985, this compound "may reasonably be anticipated to be a carcinogen." (Merck, 11th ed) Butter Yellow,Dimethylaminoazobenzene,4-Dimethylaminoazobenzene,Methyl Yellow,p-Dimethylaminoazobenzene, (E)-Isomer,p-Dimethylaminoazobenzene, (Z)-Isomer,4 Dimethylaminoazobenzene,p Dimethylaminoazobenzene
D006900 Hydroxylation Placing of a hydroxyl group on a compound in a position where one did not exist before. (Stedman, 26th ed) Hydroxylations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
January 1984, Experimental pathology,
H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
September 1979, Radioisotopes,
H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
February 1981, Radioisotopes,
H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
February 1981, Gan,
H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
September 1972, International journal of cancer,
H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
December 1971, Gan,
H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
October 1975, Gan,
H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
December 1978, Gan,
H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
October 1979, Laboratory animals,
H Mori, and T Tanaka, and S Sugie, and T Kuniyasu, and H Iwata, and H Ni-i, and A Nishiwaki, and Y Mori
February 1981, FEBS letters,
Copied contents to your clipboard!